FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Julie Crockett

Research Profile

Anatomy

Chemicals & Drugs

Physiology

Living Beings

Disorders

Osteopetrosis

Co-author Network

Publications

TOP 3
Alessandra Pangrazio; Claire Schlack; Ansgar Schulz; D Strina; Ashok Vellodi; Paul Veys; Paolo Vezzoni; Anna Villa; Luca Zammataro; Barbara Cassani; Robert Chiesa; Julie Crockett; Anne Durandy; Angela Duthie; Alain Fischer; Matteo M Guerrini; Miep H Helfrich; Uwe Kornak; Nadia Lo Iacono; Veronica Marrella; David J Mellis; Despina Moshous; Cristina Sobacchi
RANK-dependent autosomal recessive osteopetrosis: characterization of five new cases with novel mutations.
Julie Crockett; Angela Duthie; John Greenhorn; Miep H Helfrich; David J Mellis; Stuart H Ralston; Kathleen Ij Shennan; Debbie I Wilkinson; Michael J Rogers
Signal peptide mutations in RANK prevent downstream activation of NF-κB.
Michael J Rogers; Fraser Coxon; Julie Crockett; Jukka Mönkkönen
Biochemical and molecular mechanisms of action of bisphosphonates.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Julie Crockett (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Alessandra Pangrazio; Claire Schlack; Ansgar Schulz; D Strina; Ashok Vellodi; Paul Veys; Paolo Vezzoni; Anna Villa; Luca Zammataro; Barbara Cassani; Robert Chiesa; Julie Crockett; Anne Durandy; Angela Duthie; Alain Fischer; Matteo M Guerrini; Miep H Helfrich; Uwe Kornak; Nadia Lo Iacono; Veronica Marrella; David J Mellis; Despina Moshous; Cristina Sobacchi
RANK-dependent autosomal recessive osteopetrosis: characterization of five new cases with novel mutations.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2012;27(2):342-51.
2011: Julie Crockett; Angela Duthie; John Greenhorn; Miep H Helfrich; David J Mellis; Stuart H Ralston; Kathleen Ij Shennan; Debbie I Wilkinson; Michael J Rogers
Signal peptide mutations in RANK prevent downstream activation of NF-κB.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2011;26(8):1926-38.
2011: Michael J Rogers; Fraser Coxon; Julie Crockett; Jukka Mönkkönen
Biochemical and molecular mechanisms of action of bisphosphonates.
Bone 2011;49(1):34-41.
2011: Julie Crockett; D J Mellis; D I Scott; Miep H Helfrich
New knowledge on critical osteoclast formation and activation pathways from study of rare genetic diseases of osteoclasts: focus on the RANK/RANKL axis.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2011;22(1):1-20.
2009: Johanna Räikkönen; Julie Crockett; Michael J Rogers; Hannu Mönkkönen; Seppo Auriola; Jukka Mönkkönen
Zoledronic acid induces formation of a pro-apoptotic ATP analogue and isopentenyl pyrophosphate in osteoclasts in vivo and in MCF-7 cells in vitro.
British journal of pharmacology 2009;157(3):427-35.
2008: Matteo M Guerrini; Cristina Sobacchi; Barbara Cassani; Mario Abinun; Sara S Kilic; Alessandra Pangrazio; Daniele Moratto; Evelina Mazzolari; Jill Clayton-Smith; Paul Orchard; Fraser Coxon; Miep H Helfrich; Julie Crockett; David Mellis; Ashok Vellodi; Ilhan Tezcan; Luigi D Notarangelo; Michael J Rogers; Paolo Vezzoni; Anna Villa; Annalisa Frattini
Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations.
American journal of human genetics 2008;83(1):64-76.
2007: Julie Crockett; Norbert Schütze; Denise Tosh; Susanne Jatzke; Angela Duthie; Franz Jakob; Michael J Rogers
The matricellular protein CYR61 inhibits osteoclastogenesis by a mechanism independent of alphavbeta3 and alphavbeta5.
Endocrinology 2007;148(12):5761-8.
2007: Alun Hughes; Michael J Rogers; Aymen I Idris; Julie Crockett
A comparison between the effects of hydrophobic and hydrophilic statins on osteoclast function in vitro and ovariectomy-induced bone loss in vivo.
Calcified tissue international 2007;81(5):403-13.
2006: Keith Thompson; Michael J Rogers; Fraser Coxon; Julie Crockett
Cytosolic entry of bisphosphonate drugs requires acidification of vesicles after fluid-phase endocytosis.
Molecular pharmacology 2006;69(5):1624-32.
2003: Neil W A McGowan; Heather MacPherson; Katrien Janssens; Wim Van Hul; Julie Crockett; William D Fraser; Stuart H Ralston; Miep H Helfrich
A mutation affecting the latency-associated peptide of TGFbeta1 in Camurati-Engelmann disease enhances osteoclast formation in vitro.
The Journal of clinical endocrinology and metabolism 2003;88(7):3321-6.
2003: Julie Crockett; Michael J Rogers
Antagonistic effects of different classes of bisphosphonates in osteoclasts and macrophages in vitro.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2003;18(2):204-12.
2003: Fraser Coxon; Julie Crockett; Helena L Benford; Michael J Rogers
Isolation and purification of rabbit osteoclasts.
Methods in molecular medicine 2003;80():89-99.
2003: Ada Staal; Julie Crockett; Michele H French; Joann Swartz; Timur Güngör; Thomas Harrity; Joseph Tamasi; Michael J Rogers; Jean H M Feyen
The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2003;18(1):88-96.
2001: Julie Crockett; Jukka Mönkkönen; Seppo Auriola; Hannu Mönkkönen; Michael J Rogers
The molecular mechanism of action of the antiresorptive and antiinflammatory drug clodronate: evidence for the formation in vivo of a metabolite that inhibits bone resorption and causes osteoclast and macrophage apoptosis.
Arthritis and rheumatism 2001;44(9):2201-10.
2000: Michael J Rogers; Sharon Gordon; Helena L Benford; Fraser Coxon; Steven P Luckman; J Monkkonen; Julie Crockett
Cellular and molecular mechanisms of action of bisphosphonates.
Cancer 2000;88(12 Suppl):2961-78.
2000: Hannu Mönkkönen; P Moilanen; Jukka Mönkkönen; Julie Crockett; Michael J Rogers; Seppo Auriola
Analysis of an adenine nucleotide-containing metabolite of clodronate using ion pair high-performance liquid chromatography-electrospray ionisation mass spectrometry.
Journal of chromatography. B, Biomedical sciences and applications 2000;738(2):395-403.
1999: R Graham G Russell; Michael J Rogers; Julie Crockett; Steven P Luckman; Fraser Coxon; Helena L Benford; Peter I Croucher; Claire M Shipman; H A Fleisch
The pharmacology of bisphosphonates and new insights into their mechanisms of action.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1999;14 Suppl 2():53-65.
1999: Helena L Benford; Julie Crockett; Seppo Auriola; Jukka Mönkkönen; Michael J Rogers
Farnesol and geranylgeraniol prevent activation of caspases by aminobisphosphonates: biochemical evidence for two distinct pharmacological classes of bisphosphonate drugs.
Molecular pharmacology 1999;56(1):131-40.
1999: Michael J Rogers; Julie Crockett; Steven P Luckman; Fraser Coxon; Helena L Benford; Jukka Mönkkönen; Seppo Auriola; K M Chilton; R Graham G Russell
Molecular mechanisms of action of bisphosphonates.
Bone 1999;24(5 Suppl):73S-79S.
1999: N Makkonen; A Salminen; Michael J Rogers; Julie Crockett; Arto Urtti; Elena Azhayeva; Jukka Mönkkönen
Contrasting effects of alendronate and clodronate on RAW 264 macrophages: the role of a bisphosphonate metabolite.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 1999;8(2):109-18.
1997: Seppo Auriola; Julie Crockett; Michael J Rogers; A Koivuniemi; Jukka Mönkkönen
Identification of adenine nucleotide-containing metabolites of bisphosphonate drugs using ion-pair liquid chromatography-electrospray mass spectrometry.
Journal of chromatography. B, Biomedical sciences and applications 1997;704(1-2):187-95.
1997: Julie Crockett; Jukka Mönkkönen; G Michael Blackburn; R Graham G Russell; Michael J Rogers
Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5'-(beta, gamma-dichloromethylene) triphosphate, by mammalian cells in vitro.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1997;12(9):1358-67.